Literature DB >> 21107559

Long-term smoking causes more advanced coronary endothelial dysfunction in middle-aged smokers compared to young smokers.

Masanao Naya1, Koichi Morita, Keiichiro Yoshinaga, Osamu Manabe, Daisuke Goto, Kenji Hirata, Chietsugu Katoh, Nagara Tamaki, Hiroyuki Tsutsui.   

Abstract

PURPOSE: Smoking cessation has been shown to normalize the coronary endothelial dysfunction in healthy young smokers. However, its effect has not been explored in middle-aged smokers with a longer history of smoking. Therefore, we compared the effects of smoking cessation on coronary vasomotor response between both young and middle-aged smokers and identified the predictor for its improvement.
METHODS: This study investigated 14 young healthy smokers (age 25.2 ± 2.3 years), 13 middle-aged smokers (age 42.0 ± 6.5 years) and 10 non-smokers. Myocardial blood flow (MBF) was measured by using (15)O-water positron emission tomography (PET).
RESULTS: At baseline, the ratio of MBF during the cold pressor test (CPT) to that at rest (MBF(CPT/rest)), the index of coronary endothelial function, was significantly decreased in both young and middle-aged smokers compared to non-smokers (1.24 ± 0.20 and 1.10 ± 0.39 vs 1.53 ± 0.18, p < 0.05 and p < 0.001, respectively). The ratio of MBF during adenosine triphosphate infusion to that at rest was significantly decreased in middle-aged smokers compared to young smokers and non-smokers (3.34 ± 1.52 vs 4.43 ± 0.92 and 4.69 ± 1.25, p < 0.05, respectively). MBF(CPT/rest) at 1 month after smoking cessation significantly increased in young smokers, but not in middle-aged smokers. By multivariate analysis, baseline serum malondialdehyde-modified low-density lipoprotein (MDA-LDL) was an independent predictor for the changes in MBF(CPT/rest) after smoking cessation (β = -0.45, p < 0.05).
CONCLUSION: Coronary endothelial dysfunction was reversible by short-term smoking cessation in young smokers, but not in middle-aged smokers, which was associated with serum MDA-LDL levels. Long-term smoking exposure could lead to more advanced coronary endothelial dysfunction and atherosclerosis possibly via oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107559     DOI: 10.1007/s00259-010-1647-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  24 in total

1.  Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease.

Authors:  Takahiro Tsukamoto; Koichi Morita; Masanao Naya; Chietsugu Katoh; Masayuki Inubushi; Yuji Kuge; Hiroyuki Tsutsui; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-30       Impact factor: 9.236

2.  Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography.

Authors:  K L Gould; Y Nakagawa; K Nakagawa; S Sdringola; M J Hess; M Haynie; N Parker; N Mullani; R Kirkeeide
Journal:  Circulation       Date:  2000-04-25       Impact factor: 29.690

3.  Are patients truthful about their smoking habits? A validation of self-report about smoking cessation with biochemical markers of smoking activity amongst patients with ischaemic heart disease.

Authors:  M From Attebring; J Herlitz; A K Berndt; T Karlsson; A Hjalmarson
Journal:  J Intern Med       Date:  2001-02       Impact factor: 8.989

4.  Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT.

Authors:  Ines Valenta; Alessandra Quercioli; Gabriella Vincenti; René Nkoulou; Stephan Dewarrat; Olivier Rager; Habib Zaidi; Yann Seimbille; Francois Mach; Osman Ratib; Thomas H Schindler
Journal:  J Nucl Cardiol       Date:  2010-07-24       Impact factor: 5.952

5.  Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function.

Authors:  P A Kaufmann; T Gnecchi-Ruscone; M di Terlizzi; K P Schäfers; T F Lüscher; P G Camici
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

6.  Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans.

Authors:  John O Prior; Thomas H Schindler; Alvaro D Facta; Miguel Hernandez-Pampaloni; Roxana Campisi; Magnus Dahlbom; Heinrich R Schelbert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-11       Impact factor: 9.236

7.  Smoking cessation normalizes coronary endothelial vasomotor response assessed with 15O-water and PET in healthy young smokers.

Authors:  Koichi Morita; Takahiro Tsukamoto; Masanao Naya; Kazuyuki Noriyasu; Masayuki Inubushi; Tohru Shiga; Chietsugu Katoh; Yuji Kuge; Hiroyuki Tsutsui; Nagara Tamaki
Journal:  J Nucl Med       Date:  2006-12       Impact factor: 10.057

8.  The risk of myocardial infarction after quitting smoking in men under 55 years of age.

Authors:  L Rosenberg; D W Kaufman; S P Helmrich; S Shapiro
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

9.  Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL.

Authors:  T Heitzer; S Ylä-Herttuala; J Luoma; S Kurz; T Münzel; H Just; M Olschewski; H Drexler
Journal:  Circulation       Date:  1996-04-01       Impact factor: 29.690

10.  Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients.

Authors:  Masanao Naya; Takahiro Tsukamoto; Koichi Morita; Chietsugu Katoh; Tomoo Furumoto; Satoshi Fujii; Nagara Tamaki; Hiroyuki Tsutsui
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

View more
  7 in total

Review 1.  Assessment of coronary endothelial function using PET.

Authors:  Keiichiro Yoshinaga; Osamu Manabe; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

2.  Altered coronary endothelial function in young smokers detected by magnetic resonance assessment of myocardial blood flow during the cold pressor test.

Authors:  Yasutaka Ichikawa; Kakuya Kitagawa; Shingo Kato; Kaoru Dohi; Tadanori Hirano; Masaaki Ito; Hajime Sakuma
Journal:  Int J Cardiovasc Imaging       Date:  2014-02-12       Impact factor: 2.357

3.  Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Wilson Nadruz; Alexandra Gonçalves; Brian Claggett; Gabriela Querejeta Roca; Amil M Shah; Susan Cheng; Gerardo Heiss; Christie M Ballantyne; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2016-03-30       Impact factor: 15.534

Review 4.  Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis.

Authors:  Luxia Song; Jie Zhang; Runmin Lai; Qiuyi Li; Jianqing Ju; Hao Xu
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 5.  Metabolomics and cardiovascular imaging: a combined approach for cardiovascular ageing.

Authors:  Angela S Koh; Jean-Paul Kovalik
Journal:  ESC Heart Fail       Date:  2021-03-30

6.  Modification of the association between smoking status and severity of coronary stenosis by vitamin D in patients suspected of coronary heart disease.

Authors:  Kuibao Li; Xiyan Yang; Lefeng Wang; Mulei Chen; Wenshu Zhao; Li Xu; Xinchun Yang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

7.  Radiopharmaceutical tracers for cardiac imaging.

Authors:  Osamu Manabe; Tatsuya Kikuchi; Arthur J H A Scholte; Mohammed El Mahdiui; Ryuichi Nishii; Ming-Rong Zhang; Eriko Suzuki; Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2017-12-01       Impact factor: 5.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.